Related Experiment Video
Updated: May 12, 2026

A Periprosthetic Joint Candida albicans Infection Model in Mouse
Published on: February 2, 2024
Periprosthetic metastasis: a rare cause for prosthetic loosening
Mathias Thomas Nagy1, Andrew Fred Young, Neshteman Gorgees
1Department of Trauma and Orthopaedic Surgery, Kettering General Hospital, Kettering, UK. dr.nagy@gmx.net
Abstract:
Malignant periprosthetic metastasis is a very rare yet important cause of painful joint arthroplasty. This study presents a case in which periprosthetic osteolysis following total hip replacement (THR) occurred as a result of metastatic mesothelioma. After a THR and revision THR, histopathology confirmed the diagnosis of metastatic mesothelioma. Primary lesion was identified using CT scan of the chest. Patient is receiving palliative chemotherapy.
Insights
Metastatic mesothelioma is a rare cause of painful periprosthetic osteolysis after total hip replacement (THR). This case highlights the importance of considering metastatic disease in patients with joint arthroplasty complications.
Area of Science:
- Oncology
- Orthopedic Surgery
- Pathology
Background:
- Malignant periprosthetic metastasis is a rare complication of joint arthroplasty.
- Painful joint arthroplasty can be caused by various factors, including infection, loosening, and malignancy.
Observation:
- This study details a unique case of periprosthetic osteolysis following total hip replacement (THR).
- The osteolysis was attributed to metastatic mesothelioma, a rare form of cancer.
Findings:
- Histopathology after THR and revision THR confirmed metastatic mesothelioma.
- A CT scan of the chest identified the primary mesothelioma lesion.
Implications:
- This case underscores the necessity of considering metastatic disease in the differential diagnosis of painful periprosthetic osteolysis.
- Early identification and management of metastatic periprosthetic lesions are crucial for patient outcomes.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
